Glymphatic dysfunction in multiple sclerosis and its association with disease pathology and disability.

IF 4.8 2区 医学 Q1 CLINICAL NEUROLOGY Multiple Sclerosis Journal Pub Date : 2024-11-01 Epub Date: 2024-09-29 DOI:10.1177/13524585241280842
Ahmed Bayoumi, Khader M Hasan, Joseph A Thomas, Akram Yazdani, John A Lincoln
{"title":"Glymphatic dysfunction in multiple sclerosis and its association with disease pathology and disability.","authors":"Ahmed Bayoumi, Khader M Hasan, Joseph A Thomas, Akram Yazdani, John A Lincoln","doi":"10.1177/13524585241280842","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The role of the glymphatic system in multiple sclerosis (MS)-related disability remains underexplored. Diffusion-tensor image analysis along the perivascular space (DTI-ALPS) offers a non-invasive method to assess glymphatic function.</p><p><strong>Objective: </strong>To evaluate glymphatic function in MS patients with lower and higher disability.</p><p><strong>Methods: </strong>This study included 118 MS patients who underwent structural, diffusion-weighted imaging, and clinical assessment. The participants were divided into lower (MS-L, <i>n</i> = 57) and higher disability (MS-H, <i>n</i> = 61) subgroups. Brain parenchymal fraction (BPF), lesion load (LL), and DTI-ALPS index were measured. Subgroup differences and correlations between DTI-ALPS index and other measures were explored. Logistic regression was performed to evaluate BPF, LL, and DTI-ALPS index in classifying lower and higher disability patients.</p><p><strong>Results: </strong>Significant differences in DTI-ALPS index between MS-H and MS-L (<i>d</i> = -0.71, false discovery rate-corrected <i>p</i>-value (<i>p-</i>FDR) = 0.001) were found. The DTI-ALPS index correlated significantly with disease duration (<i>r<sub>p</sub></i> = -0.29, <i>p-</i>FDR = 0.002) and EDSS (<i>r<sub>sp</sub></i> = -0.35, <i>p-</i>FDR = 0.0002). It also showed significant correlations with BPF and LL. DTI-ALPS index and LL were significant predictors of disability subgroup (DTI-ALPS: odds ratio (OR) = 1.77, <i>p</i> = 0.04, LL: OR = 0.94, <i>p</i> = 0.02).</p><p><strong>Conclusion: </strong>Our findings highlight DTI-ALPS index as an imaging biomarker in MS, suggesting the involvement of glymphatic impairment in MS pathology, although further research is needed to elucidate its role in contributing to MS-related disability.</p>","PeriodicalId":18874,"journal":{"name":"Multiple Sclerosis Journal","volume":" ","pages":"1609-1619"},"PeriodicalIF":4.8000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11568644/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Multiple Sclerosis Journal","FirstCategoryId":"88","ListUrlMain":"https://doi.org/10.1177/13524585241280842","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/9/29 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The role of the glymphatic system in multiple sclerosis (MS)-related disability remains underexplored. Diffusion-tensor image analysis along the perivascular space (DTI-ALPS) offers a non-invasive method to assess glymphatic function.

Objective: To evaluate glymphatic function in MS patients with lower and higher disability.

Methods: This study included 118 MS patients who underwent structural, diffusion-weighted imaging, and clinical assessment. The participants were divided into lower (MS-L, n = 57) and higher disability (MS-H, n = 61) subgroups. Brain parenchymal fraction (BPF), lesion load (LL), and DTI-ALPS index were measured. Subgroup differences and correlations between DTI-ALPS index and other measures were explored. Logistic regression was performed to evaluate BPF, LL, and DTI-ALPS index in classifying lower and higher disability patients.

Results: Significant differences in DTI-ALPS index between MS-H and MS-L (d = -0.71, false discovery rate-corrected p-value (p-FDR) = 0.001) were found. The DTI-ALPS index correlated significantly with disease duration (rp = -0.29, p-FDR = 0.002) and EDSS (rsp = -0.35, p-FDR = 0.0002). It also showed significant correlations with BPF and LL. DTI-ALPS index and LL were significant predictors of disability subgroup (DTI-ALPS: odds ratio (OR) = 1.77, p = 0.04, LL: OR = 0.94, p = 0.02).

Conclusion: Our findings highlight DTI-ALPS index as an imaging biomarker in MS, suggesting the involvement of glymphatic impairment in MS pathology, although further research is needed to elucidate its role in contributing to MS-related disability.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
多发性硬化症的淋巴功能障碍及其与疾病病理和残疾的关系。
背景:甘液系统在多发性硬化症(MS)相关残疾中的作用仍未得到充分探索。沿血管周围空间的弥散张量图像分析(DTI-ALPS)提供了一种非侵入性方法来评估肾脏功能:评估多发性硬化症低度和高度致残患者的肾脏功能:本研究纳入了 118 名接受结构、弥散加权成像和临床评估的多发性硬化症患者。参与者被分为残疾程度较低(MS-L,n = 57)和残疾程度较高(MS-H,n = 61)两组。对脑实质部分(BPF)、病变负荷(LL)和DTI-ALPS指数进行了测量。探讨了亚组差异以及 DTI-ALPS 指数与其他测量指标之间的相关性。对BPF、LL和DTI-ALPS指数进行了逻辑回归,以评估其对残疾程度较低和较高的患者的分级作用:DTI-ALPS指数在MS-H和MS-L之间存在显著差异(d = -0.71,假发现率校正p值(p-FDR) = 0.001)。DTI-ALPS 指数与病程(rp = -0.29,p-FDR = 0.002)和 EDSS(rsp = -0.35,p-FDR = 0.0002)显著相关。它与 BPF 和 LL 也有明显的相关性。DTI-ALPS 指数和 LL 是残疾亚组的重要预测指标(DTI-ALPS:比值比 (OR) = 1.77,P = 0.04;LL:OR = 0.94,P = 0.02):我们的研究结果表明,DTI-ALPS指数是多发性硬化症的一种影像生物标志物,提示多发性硬化症病理中存在肾上腺功能损害,但仍需进一步研究以阐明其在多发性硬化症相关残疾中的作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Multiple Sclerosis Journal
Multiple Sclerosis Journal 医学-临床神经学
CiteScore
10.90
自引率
6.90%
发文量
186
审稿时长
3-8 weeks
期刊介绍: Multiple Sclerosis Journal is a peer-reviewed international journal that focuses on all aspects of multiple sclerosis, neuromyelitis optica and other related autoimmune diseases of the central nervous system. The journal for your research in the following areas: * __Biologic basis:__ pathology, myelin biology, pathophysiology of the blood/brain barrier, axo-glial pathobiology, remyelination, virology and microbiome, immunology, proteomics * __Epidemology and genetics:__ genetics epigenetics, epidemiology * __Clinical and Neuroimaging:__ clinical neurology, biomarkers, neuroimaging and clinical outcome measures * __Therapeutics and rehabilitation:__ therapeutics, rehabilitation, psychology, neuroplasticity, neuroprotection, and systematic management Print ISSN: 1352-4585
期刊最新文献
Challenges and implications of anti-JCV antibody serology variability among different assays in natalizumab treatment: A call for standardization and transparency in clinical practice. Homonymous hemi-macular atrophy in multiple sclerosis. Cryptogenic organising pneumonia in patients treated with ocrelizumab. Ocrelizumab-associated cryptogenic organizing pneumonia in multiple sclerosis: Two case reports and comprehensive literature review. Vaccination as a risk factor for pediatric multiple sclerosis: Insights from a retrospective case-control study.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1